{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:18:23Z","timestamp":1783419503708,"version":"3.54.6"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012681","name":"Universit\u00e4tsklinikum K\u00f6ln","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012681","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-hyperemic pressure ratios are recommended to assess intermediate coronary lesions. Evidence on outcomes after deferral of revascularization based on resting full-cycle ratio (RFR) remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to assess clinical outcomes over 2\u00a0years following revascularization deferral guided by RFR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed 773 patients with 1012 intermediate coronary lesions undergoing RFR assessment between 2016 and 2022 at the University Hospital Cologne resulting in revascularization deferral. Lesions were stratified into three RFR groups:\u2009&lt;\u20090.93, 0.93\u20130.95, and\u2009&gt;\u20090.95. The primary endpoint was the 2-year incidence of major cardiac adverse events (MACE), defined as a composite of cardiovascular death, myocardial infarction, or stroke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients presented with silent ischemia (35.4%), stable (30.9%) or atypical angina (20.1%), and unstable angina (13.6%). Over 2-year MACE occurred in 8.1% of lesions and 7.8% of patients, while death of any cause was documented in 86 patients (11.1%). MACE were similar across RFR groups, though target-vessel revascularization and target-vessel ischemia-driven revascularization were more frequent in patients with RFR\u2009&lt;\u20090.93 (HR, 3.14 [95% CI 1.35\u20137.30,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008 and 2.42 [95% CI 1.01\u20135.84],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.048). Chronic obstructive pulmonary disease, age, peripheral artery disease, atrial fibrillation, diffuse coronary disease, and heavy calcification were associated with 2-year MACE.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this all-comers cohort, the 2-year MACE-rate after RFR-guided deferral was 8.1%. Higher revascularization rates in lesions with RFR\u2009\u2264\u20090.93 suggest the need for further evaluation, especially in the presence of high-risk features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                    <jats:p>Central Illustration: Long-Term outcomes after RFR and deferral of revascularization<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00392-026-02977-5","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:08:44Z","timestamp":1783415324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term outcomes after resting full-cycle ratio and deferral of revascularization"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5779-7549","authenticated-orcid":false,"given":"Stephan","family":"Nienaber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Wind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Mauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Finke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Guthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Baldus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Halbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Wienemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"8","key":"2977_CR1","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","volume":"149","author":"SS Martin","year":"2024","unstructured":"Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL et al (2024) Heart disease and stroke statistics: a report of US and global data from the American heart association. Circulation 149(8):e347\u2013e913","journal-title":"Circulation"},{"key":"2977_CR2","unstructured":"Eurostat EU (2020) Deaths due to coronary heart diseases in the EU: European Union. Available from: https:\/\/ec.europa.eu\/eurostat\/web\/products-eurostat-news\/-\/EDN-20200928-1?utm_.\u00a0Accessed 28 Oct 2025"},{"key":"2977_CR3","doi-asserted-by":"crossref","unstructured":"Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van' t Veer M et al (2009) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360(3):213\u201324","DOI":"10.1056\/NEJMoa0807611"},{"issue":"11","key":"2977_CR4","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1205361","volume":"367","author":"BD Bruyne","year":"2012","unstructured":"Bruyne BD, Pijls NHJ, Kalesan B, Barbato E, Tonino PAL, Piroth Z et al (2012) Fractional flow reserve\u2013guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367(11):991\u20131001","journal-title":"N Engl J Med"},{"key":"2977_CR5","doi-asserted-by":"crossref","unstructured":"Pijls Nico HJ, van Schaardenburgh P, Manoharan G, Boersma E, Bech J-W, van\u2019t Veer M et al (2007) Percutaneous coronary intervention of functionally nonsignificant stenosis. JACC 49(21):2105\u201311","DOI":"10.1016\/j.jacc.2007.01.087"},{"issue":"45","key":"2977_CR6","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1093\/eurheartj\/ehv452","volume":"36","author":"FM Zimmermann","year":"2015","unstructured":"Zimmermann FM, Ferrara A, Johnson NP, van Nunen LX, Escaned J, Albertsson P et al (2015) Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. Eur Heart J 36(45):3182\u20133188","journal-title":"Eur Heart J"},{"issue":"11","key":"2977_CR7","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.jcin.2011.09.007","volume":"4","author":"O Muller","year":"2011","unstructured":"Muller O, Mangiacapra F, Ntalianis A, Verhamme KMC, Trana C, Hamilos M et al (2011) Long-term follow-up after fractional flow reserve\u2013guided treatment strategy in patients with an isolated proximal left anterior descending coronary artery stenosis. JACC Cardiovasc Interv 4(11):1175\u20131182","journal-title":"JACC Cardiovasc Interv"},{"issue":"18","key":"2977_CR8","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/eurheartj\/eht005","volume":"34","author":"J Li","year":"2013","unstructured":"Li J, Elrashidi MY, Flammer AJ, Lennon RJ, Bell MR, Holmes DR et al (2013) Long-term outcomes of fractional flow reserve-guided vs. angiography-guided percutaneous coronary intervention in contemporary practice. Eur Heart J 34(18):1375\u201383","journal-title":"Eur Heart J"},{"issue":"15","key":"2977_CR9","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1161\/CIRCULATIONAHA.109.850073","volume":"120","author":"M Hamilos","year":"2009","unstructured":"Hamilos M, Muller O, Cuisset T, Ntalianis A, Chlouverakis G, Sarno G et al (2009) Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis. Circulation 120(15):1505\u20131512","journal-title":"Circulation"},{"issue":"2","key":"2977_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"FJ Neumann","year":"2019","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U et al (2019) 2018 ESC\/EACTS Guidelines on myocardial revascularization. Eur Heart J 40(2):87\u2013165","journal-title":"Eur Heart J"},{"issue":"2","key":"2977_CR11","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","volume":"79","author":"JS Lawton","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM et al (2022) 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 79(2):e21\u2013e129","journal-title":"J Am Coll Cardiol"},{"issue":"36","key":"2977_CR12","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J et al (2024) 2024 ESC Guidelines for the management of chronic coronary syndromes: developed by the task force for the management of chronic coronary syndromes of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 45(36):3415\u20133537","journal-title":"Eur Heart J"},{"issue":"19","key":"2977_CR13","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa1700445","volume":"376","author":"JE Davies","year":"2017","unstructured":"Davies JE, Sen S, Dehbi HM, Al-Lamee R, Petraco R, Nijjer SS et al (2017) Use of the instantaneous wave-free ratio or fractional flow reserve in PCI. N Engl J Med 376(19):1824\u20131834","journal-title":"N Engl J Med"},{"issue":"4","key":"2977_CR14","doi-asserted-by":"publisher","first-page":"e008487","DOI":"10.1161\/CIRCINTERVENTIONS.119.008487","volume":"13","author":"GL De Maria","year":"2020","unstructured":"De Maria GL, Garcia-Garcia HM, Scarsini R, Hideo-Kajita A, Gonzalo L\u00f3pez N, Leone AM et al (2020) Novel indices of coronary physiology: do we need alternatives to fractional flow reserve? Circ Cardiovasc Interv 13(4):e008487","journal-title":"Circ Cardiovasc Interv"},{"issue":"19","key":"2977_CR15","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa1616540","volume":"376","author":"M G\u00f6tberg","year":"2017","unstructured":"G\u00f6tberg M, Christiansen EH, Gudmundsdottir IJ, Sandhall L, Danielewicz M, Jakobsen L et al (2017) Instantaneous wave-free ratio versus fractional flow reserve to guide PCI. N Engl J Med 376(19):1813\u20131823","journal-title":"N Engl J Med"},{"issue":"7","key":"2977_CR16","doi-asserted-by":"publisher","first-page":"806","DOI":"10.4244\/EIJ-D-18-00342","volume":"14","author":"J Svanerud","year":"2018","unstructured":"Svanerud J, Ahn JM, Jeremias A, van \u2019t Veer M, Gore A, Maehara A et al (2018) Validation of a novel non-hyperaemic index of coronary artery stenosis severity: the Resting Full-cycle Ratio (VALIDATE RFR) study. EuroIntervention 14(7):806\u2013814","journal-title":"EuroIntervention"},{"issue":"1","key":"2977_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/jamacardio.2024.3314","volume":"10","author":"J Escaned","year":"2025","unstructured":"Escaned J, Travieso A, Dehbi HM, Nijjer SS, Sen S, Petraco R et al (2025) Coronary revascularization guided with fractional flow reserve or instantaneous wave-free ratio: a 5-year follow-up of the DEFINE FLAIR randomized clinical trial. JAMA Cardiol 10(1):25\u201331","journal-title":"JAMA Cardiol"},{"issue":"4","key":"2977_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jcin.2024.12.003","volume":"18","author":"M G\u00f6tberg","year":"2025","unstructured":"G\u00f6tberg M, Berntorp K, Jeremias A, Yndigegn T, von Koch S, Linder R et al (2025) Long-term clinical outcomes after IFR- vs FFR-guided coronary revascularization: insights from the SWEDEHEART National Registry. JACC Cardiovasc Interv 18(4):455\u2013467","journal-title":"JACC Cardiovasc Interv"},{"issue":"13","key":"2977_CR19","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.jacc.2012.09.064","volume":"61","author":"NP Johnson","year":"2013","unstructured":"Johnson NP, Kirkeeide RL, Asrress KN, Fearon WF, Lockie T, Marques KM et al (2013) Does the instantaneous wave-free ratio approximate the fractional flow reserve? J Am Coll Cardiol 61(13):1428\u20131435","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2977_CR20","doi-asserted-by":"publisher","first-page":"450","DOI":"10.4244\/EIJ-D-16-00456","volume":"13","author":"GA de Waard","year":"2017","unstructured":"de Waard GA, Di Mario C, Lerman A, Serruys PW, van Royen N (2017) Instantaneous wave-free ratio to guide coronary revascularisation: physiological framework, validation and differences from fractional flow reserve. EuroIntervention 13(4):450\u2013458","journal-title":"EuroIntervention"},{"issue":"25","key":"2977_CR21","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1016\/j.jacc.2017.10.066","volume":"70","author":"M van't Veer","year":"2017","unstructured":"van\u2019t Veer M, Pijls NHJ, Hennigan B, Watkins S, Ali ZA, De Bruyne B et al (2017) Comparison of different diastolic resting indexes to iFR: are they all equal? J Am Coll Cardiol 70(25):3088\u20133096","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2977_CR22","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1161\/CIRCULATIONAHA.124.071139","volume":"151","author":"S Kuramitsu","year":"2025","unstructured":"Kuramitsu S, Kawase Y, Shinozaki T, Domei T, Yamanaka F, Kaneko U et al (2025) Prevalence and clinical outcomes of discordant lesions between fractional flow reserve and nonhyperemic pressure ratios in clinical practice: the J-PRIDE Registry. Circulation 151(10):672\u2013685","journal-title":"Circulation"},{"issue":"41","key":"2977_CR23","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.1093\/eurheartj\/ehad582","volume":"44","author":"A Eftekhari","year":"2023","unstructured":"Eftekhari A, Holck EN, Westra J, Olsen NT, Bruun NH, Jensen LO et al (2023) Instantaneous wave free ratio vs. fractional flow reserve and 5-year mortality: iFR SWEDEHEART and DEFINE FLAIR. Eur Heart J 44(41):4376\u20134384","journal-title":"Eur Heart J"},{"issue":"13","key":"2977_CR24","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.jcin.2025.05.032","volume":"18","author":"ET Ha","year":"2025","unstructured":"Ha ET, Nishi T, Takahashi T, Yamazaki T, Saito Y, Kuramitsu S et al (2025) Outcomes of lesions with discordance between FFR and nonhyperemic pressure ratios. JACC Cardiovasc Interv 18(13):1631\u20131642","journal-title":"JACC Cardiovasc Interv"},{"key":"2977_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/6461691","author":"S Malmberg","year":"2023","unstructured":"Malmberg S, Lauermann J, Karlstr\u00f6m P, Gulin D, Barmano N (2023) Resting full-cycle ratio versus fractional flow reserve: a SWEDEHEART-registry-based comparison of two physiological indexes for assessing coronary stenosis severity. J Interv Cardiol. https:\/\/doi.org\/10.1155\/2023\/6461691","journal-title":"J Interv Cardiol"},{"issue":"9","key":"2977_CR26","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1007\/s00392-022-02149-1","volume":"112","author":"M Halbach","year":"2023","unstructured":"Halbach M, Ameskamp C, Mauri V, Ernst A, Lake P, Nienaber S et al (2023) Prognostic impact of resting full-cycle ratio and diastolic non-hyperemic pressure ratios in patients with deferred revascularization. Clin Res Cardiol 112(9):1220\u20131230","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"2977_CR27","first-page":"91","volume":"102","author":"J Stader","year":"2023","unstructured":"Stader J, Antoniadis M, Ussat M, Wachter R, Lavall D, Metze M et al (2023) Comparison of quantitative flow ratio with instantaneous wave-free ratio and resting full-cycle ratio during daily routine in the catheterization laboratory. Catheter Cardiovasc Interv 102(1):91\u2013100","journal-title":"Catheter Cardiovasc Interv"},{"issue":"38","key":"2977_CR28","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A et al (2023) 2023 ESC Guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J 44(38):3720\u20133826","journal-title":"Eur Heart J"},{"issue":"24","key":"2977_CR29","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","volume":"137","author":"HM Garcia-Garcia","year":"2018","unstructured":"Garcia-Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, Spertus J et al (2018) Standardized end point definitions for coronary intervention trials: the Academic Research Consortium-2 Consensus Document. Circulation 137(24):2635\u20132650","journal-title":"Circulation"},{"issue":"1","key":"2977_CR30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008355","volume":"13","author":"S Kuramitsu","year":"2020","unstructured":"Kuramitsu S, Matsuo H, Shinozaki T, Horie K, Takashima H, Terai H et al (2020) Two-year outcomes after deferral of revascularization based on fractional flow reserve. Circ Cardiovasc Interv 13(1):e008355","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"2977_CR31","doi-asserted-by":"publisher","first-page":"e028423","DOI":"10.1161\/JAHA.122.028423","volume":"12","author":"K Berntorp","year":"2023","unstructured":"Berntorp K, Rylance R, Yndigegn T, Koul S, Fr\u00f6bert O, Christiansen EH et al (2023) Clinical outcome of revascularization deferral with instantaneous wave-free ratio and fractional flow reserve: a 5-year follow-up substudy from the iFR-SWEDEHEART trial. J Am Heart Assoc 12(3):e028423","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"2977_CR32","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/jamacardio.2023.2910","volume":"8","author":"JQ Mol","year":"2023","unstructured":"Mol JQ, Volleberg R, Belkacemi A, Hermanides RS, Meuwissen M, Protopopov AV et al (2023) Fractional flow reserve-negative high-risk plaques and clinical outcomes after myocardial Infarction. JAMA Cardiol 8(11):1013\u20131021","journal-title":"JAMA Cardiol"},{"key":"2977_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijcard.2018.06.013","volume":"270","author":"U Barbero","year":"2018","unstructured":"Barbero U, D\u2019Ascenzo F, Campo G, Kleczy\u0144ski P, Dziewierz A, Menozzi M et al (2018) Safety of FFR-guided revascularisation deferral in Anatomically prognostiC diseasE (FACE: CARDIOGROUP V STUDY): a prospective multicentre study. Int J Cardiol 270:107\u2013112","journal-title":"Int J Cardiol"},{"issue":"24","key":"2977_CR34","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1016\/j.jcin.2017.07.019","volume":"10","author":"JM Lee","year":"2017","unstructured":"Lee JM, Shin E-S, Nam C-W, Doh J-H, Hwang D, Park J et al (2017) Clinical outcomes according to fractional flow reserve or instantaneous wave-free ratio in deferred lesions. JACC Cardiovasc Interv 10(24):2502\u20132510","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"2977_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4244\/EIJV9I1A10","volume":"9","author":"J Iqbal","year":"2013","unstructured":"Iqbal J, Sumaya W, Tatman V, Parviz Y, Morton AC, Grech ED et al (2013) Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stenting. EuroIntervention 9(1):62\u201369","journal-title":"EuroIntervention"},{"issue":"4","key":"2977_CR36","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jacc.2022.05.017","volume":"80","author":"G Giustino","year":"2022","unstructured":"Giustino G, Colombo A, Camaj A, Yasumura K, Mehran R, Stone GW et al (2022) Coronary in-stent restenosis: JACC state-of-the-art review. J Am Coll Cardiol 80(4):348\u2013372","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"2977_CR37","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","volume":"382","author":"DJ Maron","year":"2020","unstructured":"Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O\u2019Brien SM, Boden WE et al (2020) Initial invasive or conservative strategy for stable coronary disease. N Engl J Med 382(15):1395\u20131407","journal-title":"N Engl J Med"},{"issue":"10115","key":"2977_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","volume":"391","author":"R Al-Lamee","year":"2018","unstructured":"Al-Lamee R, Thompson D, Dehbi H-M, Sen S, Tang K, Davies J et al (2018) Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet 391(10115):31\u201340","journal-title":"Lancet"},{"issue":"25","key":"2977_CR39","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1056\/NEJMoa2310610","volume":"389","author":"A Rajkumar Christopher","year":"2023","unstructured":"Rajkumar Christopher A, Foley Michael J, Ahmed-Jushuf F, Nowbar Alexandra N, SimaderFlorentina A, Davies John R et al (2023) A placebo-controlled trial of percutaneous coronary intervention for stable angina. N Engl J Med 389(25):2319\u20132330","journal-title":"N Engl J Med"},{"issue":"4","key":"2977_CR40","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jacc.2018.10.070","volume":"73","author":"S Sen","year":"2019","unstructured":"Sen S, Ahmad Y, Dehbi HM, Howard JP, Iglesias JF, Al-Lamee R et al (2019) Clinical events after deferral of LAD revascularization following physiological coronary assessment. J Am Coll Cardiol 73(4):444\u2013453","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"2977_CR41","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jacc.2016.06.035","volume":"68","author":"A Hakeem","year":"2016","unstructured":"Hakeem A, Edupuganti MM, Almomani A, Pothineni NV, Payne J, Abualsuod AM et al (2016) Long-term prognosis of deferred acute coronary syndrome lesions based on nonischemic fractional flow reserve. J Am Coll Cardiol 68(11):1181\u20131191","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"2977_CR42","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1016\/j.jacc.2020.09.547","volume":"76","author":"GW Stone","year":"2020","unstructured":"Stone GW, Maehara A, Ali ZA, Held C, Matsumura M, Kj\u00f8ller-Hansen L et al (2020) Percutaneous coronary intervention for vulnerable coronary atherosclerotic plaque. J Am Coll Cardiol 76(20):2289\u20132301","journal-title":"J Am Coll Cardiol"},{"issue":"10278","key":"2977_CR43","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0140-6736(21)00249-X","volume":"397","author":"D Erlinge","year":"2021","unstructured":"Erlinge D, Maehara A, Ben-Yehuda O, B\u00f8tker HE, Maeng M, Kj\u00f8ller-Hansen L et al (2021) Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study. Lancet 397(10278):985\u2013995","journal-title":"Lancet"},{"issue":"10438","key":"2977_CR44","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/S0140-6736(24)00413-6","volume":"403","author":"S-J Park","year":"2024","unstructured":"Park S-J, Ahn J-M, Kang D-Y, Yun S-C, Ahn Y-K, Kim W-J et al (2024) Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial. The Lancet 403(10438):1753\u20131765","journal-title":"The Lancet"},{"issue":"3","key":"2977_CR45","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/eurheartj\/ehz520","volume":"41","author":"F Prati","year":"2020","unstructured":"Prati F, Romagnoli E, Gatto L, La Manna A, Burzotta F, Ozaki Y et al (2020) Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study. Eur Heart J 41(3):383\u2013391","journal-title":"Eur Heart J"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-026-02977-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-026-02977-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-026-02977-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:04:49Z","timestamp":1783418689000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-026-02977-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":45,"alternative-id":["2977"],"URL":"https:\/\/doi.org\/10.1007\/s00392-026-02977-5","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M. Adam has received personal fees from Medtronic and personal fees from JenaValve Technology, Edwards Lifesciences, Meril Life Sciences, and Boston Scientific. S. Baldus received research grants and lecture honoraria from Edwards Lifesciences, Abbott Vascular, Boston Scientific, and JenaValve Technology. M. Halbach received lecture fees from Abbott. Dr. Wienemann reports consultancy fees and travel grants from JenaValve Technology. All other authors have no conflict of interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}